Giusi Graziano
Overview
Explore the profile of Giusi Graziano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1203
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Resta E, Graziano G, Riformato G, Noviello C, Tafuri S, Pierucci P
Respiration
. 2025 Feb;
:1-10.
PMID: 39900016
Introduction: Natural history of chronic obstructive pulmonary disease (COPD) is characterized by a progressive decline in pulmonary function and recurrent exacerbations, requiring frequent hospital admissions to medical wards. Great heterogeneity...
2.
De Cosmo S, Pontremoli R, Giandalia A, Manicardi V, Rocca A, Nicolucci A, et al.
J Nephrol
. 2024 Dec;
PMID: 39676127
Background: We evaluated the proportion of Type 2 diabetes (T2D) patients with chronic kidney disease (CKD) participating in the AMD (Association of Medical Diabetologists) Annals initiative who met the eligibility...
3.
De Matteis C, Crudele L, Di Buduo E, Cantatore S, Gadaleta R, Cariello M, et al.
Eur J Intern Med
. 2024 Oct;
131:49-57.
PMID: 39482164
Background And Aims: Homocysteine (Hcy) levels are elevated in different conditions, including cardiovascular diseases (CVD), diabetes, and metabolic-associated steatotic liver disease (MASLD). In this observational retrospective study, we analyzed Hcy...
4.
Russo G, Manicardi V, Rocca A, Nicolucci A, Giandalia A, Lucisano G, et al.
Metab Syndr Relat Disord
. 2024 Aug;
22(9):661-668.
PMID: 39088376
Familial chylomicronemia syndrome (FCS) is a rare inherited condition due to lipoprotein lipase deficiency, characterized by hyperchylomicronemia and severe hypertriglyceridemia. Diagnosis is often delayed, thus increasing the risk of acute...
5.
Cappa M, dAniello F, Digilio M, Gagliardi M, Minotti C, Leoncini P, et al.
Horm Res Paediatr
. 2024 Jul;
:1-13.
PMID: 38964306
Introduction: Growth patterns in Noonan syndrome (NS) remain relatively unknown. The objective of this study was to provide growth reference curves for patients with NS and identify correlations between their...
6.
Rossi M, Bonfanti R, Graziano G, Larosa M, Lombardo F, Nicolucci A, et al.
Acta Diabetol
. 2024 May;
61(9):1169-1176.
PMID: 38789610
Aims: Glargine 300 U/mL (Gla-300) has been recently approved for use in children and adolescents with type 1 diabetes (T1D). However, real-world effectiveness data are scarce, and aim of this...
7.
Crudele L, De Matteis C, Novielli F, Petruzzelli S, Di Buduo E, Graziano G, et al.
Intern Emerg Med
. 2024 Apr;
19(5):1267-1277.
PMID: 38668822
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the hepatic manifestation of increased adiposopathy, whose pathogenetic features have been proposed as tumourigenic triggers for colorectal cancer (CRC). We aim to...
8.
Nicolucci A, Graziano G, Lombardo F, Rabbone I, Rossi M, Vespasiani G, et al.
Acta Diabetol
. 2024 Feb;
61(5):599-607.
PMID: 38332378
Aim: In Italy, the ISPED CARD initiative was launched to measure and improve quality of care in children and adolescents with type 1 diabetes. Methods: Process and outcome indicators and...
9.
Messina S, Natale P, Graziano G, Galleggiante S, Strippoli G, Petruzzi M
Oral Dis
. 2024 Feb;
30(6):3671-3678.
PMID: 38321527
Objective: This study aimed to assess the prevalence and types of oral adverse events following immunization (AEFIs) in people who received at least one dose of any type of vaccine....
10.
Mariani A, Cavallo F, La Bella S, Graziano G, Passarelli M, Crescenzi C, et al.
Children (Basel)
. 2023 Nov;
10(11).
PMID: 38002879
Human mastadenoviruses, frequently denominated adenoviruses (HAdVs), may cause respiratory tract, gastrointestinal or, less frequently, other involvements. Epidemics of HAdV infections occur globally, in communities, and in closed or crowded settings....